JobWatch is a job posting and career development site designed exclusively for clinical research professionals of all levels. Job seekers can easily post and update resumes, apply directly for open positions and register for e-mail alerts announcing new positions. It is also the perfect resource to learn more about upcoming conferences on clinical research-related topics or register for training and academic degree programs for career development and advancement.
Sign up for your free account and find your next opportunity today!
Reach more professionals with your job posting. Jobs posted on JobWatch also appear complementary on ACRPs Career Center as part of our partnership. Your job listing receives extra exposure to the industry's largest community of clinical research professionals. Post Jobs Today.
Frenova Renal Research, a drug and medical device contract clinical development services provider dedicated to renal research, announced its opening of a new office location in downtown Durham, North Carolina, and the expansion of its U.S. field-based staff in New York, Illinois, North Carolina, Florida and Louisiana.
BioLineRx, a clinical stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, has established a joint venture (JV) with I-Bridge Capital, a Chinese venture capital fund focused on developing innovative therapies in China. The joint venture, named iPharma, will develop innovative clinical and preclinical therapeutic candidates originating primarily in Israel to serve the Chinese and global healthcare markets.
NIH Director Francis S. Collins, M.D., Ph.D., has announced the selection of Diana W. Bianchi, M.D., as director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Dr. Bianchi is expected to join NIH on Oct. 31, 2016.
BeiGene, a clinical-stage biopharmaceutical company focused on developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, has announced the appointment of Amy C. Peterson, M.D. as chief medical officer, Immuno-oncology.